Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Transgene Capital/Financing Update 2020

Jul 6, 2020

1715_rns_2020-07-06_a51eb062-0fd3-43ed-a7cb-e9a3cf02eec3.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Strasbourg, July 6, 2020 – 06:00pm CET

Half-Year Report on the Transgene Liquidity Contract with Natixis Oddo

Under the liquidity contract between Transgene and Natixis Oddo BHF SCA, on June 30, 2020, the resources provided for market making activities consisted of:

  • 218,361 Transgene Shares
  • € 217,756.50

For information, on December 31, 2019 1 , the resources provided for market making activities consisted of:

  • 164,183 Transgene Shares
  • € 246,158.00

Contacts

Transgene

Jean-Philippe Del/Lucie Larguier +33 (0)3 88 27 11 21 [email protected]

1 In light of the transfer of management of the liquidity program to Natixis Oddo BHF SCA with effect as of January 2, 2020, market making activities were suspended on December 23, 2019.